Page last updated: 2024-11-03

risperidone and Lymphoma, Large B-Cell, Diffuse

risperidone has been researched along with Lymphoma, Large B-Cell, Diffuse in 1 studies

Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.

Lymphoma, Large B-Cell, Diffuse: Malignant lymphoma composed of large B lymphoid cells whose nuclear size can exceed normal macrophage nuclei, or more than twice the size of a normal lymphocyte. The pattern is predominantly diffuse. Most of these lymphomas represent the malignant counterpart of B-lymphocytes at midstage in the process of differentiation.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Farrell, H1
Eastman, P1

Other Studies

1 other study available for risperidone and Lymphoma, Large B-Cell, Diffuse

ArticleYear
Risperidone-induced neutropenia: an adverse side-effect in the palliative management of delirium in a patient with lymphoma.
    BMJ supportive & palliative care, 2013, Volume: 3, Issue:1

    Topics: Aged, 80 and over; Antipsychotic Agents; Delirium; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Ne

2013